279 related articles for article (PubMed ID: 9080914)
1. The treatment of obesity. A call for prudence and professionalism.
Kushner R
Arch Intern Med; 1997 Mar; 157(6):602-4. PubMed ID: 9080914
[No Abstract] [Full Text] [Related]
2. Appetite suppressants for obesity.
Budenholzer B
J Fam Pract; 1997 Jan; 44(1):19-20. PubMed ID: 9010359
[No Abstract] [Full Text] [Related]
3. After fen-phen.
Cowley G; Springen K
Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270
[No Abstract] [Full Text] [Related]
4. New agent for obesity management.
Clemenson ND
J Fam Pract; 1996 Sep; 43(3):224; author reply 225. PubMed ID: 8797741
[No Abstract] [Full Text] [Related]
5. Fenfluramine and phentermine.
Howlin D
Ann Intern Med; 2001 Nov; 135(9):840-1. PubMed ID: 11694113
[No Abstract] [Full Text] [Related]
6. The pharmacologic management of obesity.
Cerda JJ
J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231
[No Abstract] [Full Text] [Related]
7. Bipolar depression associated with fenfluramine and phentermine.
Zimmer JE; Gregory RJ
J Clin Psychiatry; 1998 Jul; 59(7):383-4. PubMed ID: 9714271
[No Abstract] [Full Text] [Related]
8. Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity.
Wen PY; Feske SK; Teoh SK; Stieg PE
Neurology; 1997 Aug; 49(2):632-3. PubMed ID: 9270617
[No Abstract] [Full Text] [Related]
9. Anorectic therapy and valvular heart disease: a reappraisal.
Silvestry FE; St John Sutton M
Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
[No Abstract] [Full Text] [Related]
10. From the Food and Drug Administration.
Nightingale SL
JAMA; 1996 Jul; 276(1):14. PubMed ID: 8667525
[No Abstract] [Full Text] [Related]
11. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
Steel JM; Munro JF; Duncan LJ
Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
[No Abstract] [Full Text] [Related]
12. Dexfenfluramine, fenfluramine, and phentermine for the treatment of morbid obesity.
Torretta LK
J Am Acad Nurse Pract; 1997 Aug; 9(8):389-94, quiz 395-7. PubMed ID: 9325813
[No Abstract] [Full Text] [Related]
13. The treatment of obesity with drugs.
Hirsch J
Am J Clin Nutr; 1998 Jan; 67(1):2-4. PubMed ID: 9440366
[No Abstract] [Full Text] [Related]
14. [The role of anorexigenics in the treatment of obesity].
Laroche C; Boissonnas A
Therapie; 1979; 34(2):181-95. PubMed ID: 386556
[No Abstract] [Full Text] [Related]
15. Weighing benefits and risks of drug to treat obesity.
Sukkari SR
CMAJ; 1997 Mar; 156(6):768-9. PubMed ID: 9084379
[No Abstract] [Full Text] [Related]
16. Valvular heart disease associated with fenfluramine-phentermine.
Marshall EM
N Engl J Med; 1997 Dec; 337(24):1775; author reply 1775-6. PubMed ID: 9411252
[No Abstract] [Full Text] [Related]
17. Treatment of obesity with "combination" pharmacotherapy.
Rothman RB
Am J Ther; 2010; 17(6):596-603. PubMed ID: 19352140
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with the use of phenyltert-butylamine (phentermine) as an appetite depressant in the treatment of obesity].
Lobato DS; da Silveira DD
Hospital (Rio J); 1966 Nov; 70(5):1343-50. PubMed ID: 5301950
[No Abstract] [Full Text] [Related]
19. [Pharmacological treatment of obesity. Drugs with predominantly anorectic action].
Ortensio A; Avagnina S; Costantino A
Minerva Dietol Gastroenterol; 1988; 34(2):109-16. PubMed ID: 3050610
[No Abstract] [Full Text] [Related]
20. Anorexigen-induced cardiac valvulopathy and female gender.
Naqvi TZ; Gross SB
Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
